表紙
市場調查報告書

藥物基因體學的全球市場分析

Global Pharmacogenomics Market (2019-2025)

出版商 KBV Research 商品編碼 888301
出版日期 內容資訊 英文 256 Pages
訂單完成後即時交付
價格
Back to Top
藥物基因體學的全球市場分析 Global Pharmacogenomics Market (2019-2025)
出版日期: 2019年06月30日內容資訊: 英文 256 Pages
簡介

本報告提供全球藥物基因體學 市場相關調查分析,市場概要,各市場區隔的市場分析,競爭情形,主要企業等相關的系統性資訊。

第1章 市場範圍、手法

第2章 市場概要

  • 簡介
  • 影響市場的主要原因

第3章 全球醫藥基因學市場:各技術

  • 簡介
    • 定序
    • 聚合酵素鏈鎖反應 (PCR)
    • 電泳
    • 質譜分析
    • 微陣列
    • 其他

第4章 全球醫藥基因學市場:各適應症

  • 簡介
    • 腫瘤學
    • 精神醫學
    • 感染疾病
    • 神經疾病
    • 疼痛管理
    • 心血管疾病
    • 其他

第5章 全球醫藥基因學市場:各終端用戶

  • 簡介
    • 醫院、診所
    • 研究機關
    • 學術機構

第6章 全球醫藥基因學市場:各地區

  • 北美
  • 歐洲
  • 亞太地區
  • 南美、中東、非洲

第7章 企業簡介

  • ABBOTT Laboratories
  • Empire Genomics LLC
  • Illumina, Inc.
  • OneOme LLC
  • Myriad Genetics Inc.
  • Thermo Fischer Scientific, Inc.
  • Teva Pharmaceuticals Industries Ltd.
  • Bayer AG
  • Opko Health, Inc. (GeneDx, Inc.)
  • Becton, Dickinson and Company
目錄

The Global Pharmacogenomics Market size is expected to reach $9.9 billion by 2025, rising at a market growth of 8.8% CAGR during the forecast period.

Pharmacogenomics or personalized medicine is defined as "the tailoring of medical treatment to the specific characteristics of each patient." This concept, in reality, involves the ability to classify individuals into sub-populations which are disproportionately susceptible to a particular disease or responsive to a particular treatment. Personalized medicine emphasizes on the paradigm shift in medicine from reaction to prevention. The individual response to the drug varies according to the genetic composition. Most of the responses are positive and show improvement while few face the side effects. To address those variations, it is necessary to study how the drug processing is affected by the genes. So when the genetic variation is affecting the drug processing and response, there is the scope of the clinical study to be conducted and based on the result, adjust the dosage or to find a different drug according to the genetic composition of an individual.

Increase in the geriatric population, growing adoption of pharmacogenomics procedure by healthcare professionals, increased awareness of patients towards personalized therapy, and the emerging prevalence of chronic diseases like cancer, tuberculosis, HIV, and others, are driving the growth of pharmacogenomics market.

Based on Technology, the market is segmented into Sequencing, Polymerase Chain Reaction, Electrophoresis, Mass Spectrometry, Microarray and Others. Based on Application, the market is segmented into Oncology, Psychiatry, Infectious Diseases, Neurological Diseases, Pain management, Cardiovascular Diseases and Others. Based on End User, the market is segmented into Hospitals and Clinics, Research Institutions, and Academic Institutes. The hospitals and clinics segment accounted for the largest share among end users for pharmacogenomic products, followed by research organizations and academic institutes. This is attributed to the fact that hospitals are well-equipped with molecular diagnostic lab units to cater to the different needs of the patients. Moreover, pharmacogenomics lab units at hospitals are well-equipped with highly superior systems. Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Empire Genomics LLC, Illumina, Inc., oneome LLC, Myriad Genetics Inc., Thermo Fisher Scientific, Inc., Teva Pharmaceuticals Industries Ltd., Bayer AG, Opko Health, Inc., and Becton, Dickinson and Company.

Scope of the Study

Market Segmentation:

By Application

  • Sequencing
  • Polymerase Chain Reaction
  • Electrophoresis
  • Mass Spectrometry
  • Microarray
  • Others

By Application

  • Oncology
  • Psychiatry
  • Infectious Diseases
  • Neurological Diseases
  • Pain management
  • Cardiovascular Diseases
  • Others

By End User

  • Hospitals and Clinics
  • Research Institutions
  • Academic Institutes

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Abbott Laboratories
  • Empire Genomics LLC
  • Illumina, Inc.
  • Oneome LLC
  • Myriad Genetics Inc.
  • Thermo Fisher Scientific, Inc.
  • Teva Pharmaceuticals Industries Ltd.
  • Bayer AG
  • Opko Health, Inc.
  • Becton, Dickinson and Company

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Pharmacogenomics Market, by Application
    • 1.4.2 Global Pharmacogenomics Market, by Application
    • 1.4.3 Global Pharmacogenomics Market, by End User
    • 1.4.4 Global Pharmacogenomics Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
    • 2.1.2 Market Composition and Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Global Pharmacogenomics Market by Technology

    • 3.1.1 Global Sequencing Market by Region
    • 3.1.2 Global Polymerase Chain Reaction Market by Region
    • 3.1.3 Global Electrophoresis Market by Region
    • 3.1.4 Global Mass Spectrometry Market by Region
    • 3.1.5 Global Microarray Market by Region
    • 3.1.6 Global Others Market by Region

Chapter 4. Global Pharmacogenomics Market by Application

    • 4.1.1 Global Oncology Market by Region
    • 4.1.2 Global Psychiatry Market by Region
    • 4.1.3 Global Infectious Diseases Market by Region
    • 4.1.4 Global Neurological Diseases Market by Region
    • 4.1.5 Global Pain Management Market by Region
    • 4.1.6 Global Cardiovascular Diseases Market by Region
    • 4.1.7 Global Others Market by Region

Chapter 5. Global Pharmacogenomics Market by End User

    • 5.1.1 Global Hospitals and Clinics Market by Region
    • 5.1.2 Global Research Institutions Market by Region
    • 5.1.3 Global Academic Institutes Market by Region

Chapter 6. Global Pharmacogenomics Market by Region

  • 6.1 North America Pharmacogenomics Market
    • 6.1.1 North America Pharmacogenomics Market by Technology
      • 6.1.1.1 North America Sequencing Market by Country
      • 6.1.1.2 North America Polymerase Chain Reaction Market by Country
      • 6.1.1.3 North America Electrophoresis Market by Country
      • 6.1.1.4 North America Mass Spectrometry Market by Country
      • 6.1.1.5 North America Microarray Market by Country
      • 6.1.1.6 North America Others Market by Country
    • 6.1.2 North America Pharmacogenomics Market by Application
      • 6.1.2.1 North America Oncology Market by Country
      • 6.1.2.2 North America Psychiatry Market by Country
      • 6.1.2.3 North America Infectious Diseases Market by Country
      • 6.1.2.4 North America Neurological Diseases Market by Country
      • 6.1.2.5 North America Pain Management Market by Country
      • 6.1.2.6 North America Cardiovascular Diseases Market by Country
      • 6.1.2.7 North America Others Market by Country
    • 6.1.3 North America Pharmacogenomics Market by End User
      • 6.1.3.1 North America Hospitals and Clinics Market by Country
      • 6.1.3.2 North America Research Institutions Market by Country
      • 6.1.3.3 North America Academic Institutes Market by Country
    • 6.1.4 North America Pharmacogenomics Market by Country
      • 6.1.4.1 USA Pharmacogenomics Market
        • 6.1.4.1.1 USA Pharmacogenomics Market by Technology
        • 6.1.4.1.2 USA Pharmacogenomics Market by Application
        • 6.1.4.1.3 USA Pharmacogenomics Market by End User
      • 6.1.4.2 Canada Pharmacogenomics Market
        • 6.1.4.2.1 Canada Pharmacogenomics Market by Technology
        • 6.1.4.2.2 Canada Pharmacogenomics Market by Application
        • 6.1.4.2.3 Canada Pharmacogenomics Market by End User
      • 6.1.4.3 Mexico Pharmacogenomics Market
        • 6.1.4.3.1 Mexico Pharmacogenomics Market by Technology
        • 6.1.4.3.2 Mexico Pharmacogenomics Market by Application
        • 6.1.4.3.3 Mexico Pharmacogenomics Market by End User
      • 6.1.4.4 Rest of North America Pharmacogenomics Market
        • 6.1.4.4.1 Rest of North America Pharmacogenomics Market by Technology
        • 6.1.4.4.2 Rest of North America Pharmacogenomics Market by Application
        • 6.1.4.4.3 Rest of North America Pharmacogenomics Market by End User
  • 6.2 Europe Pharmacogenomics Market
    • 6.2.1 Europe Pharmacogenomics Market by Technology
      • 6.2.1.1 Europe Sequencing Market by Country
      • 6.2.1.2 Europe Polymerase Chain Reaction Market by Country
      • 6.2.1.3 Europe Electrophoresis Market by Country
      • 6.2.1.4 Europe Mass Spectrometry Market by Country
      • 6.2.1.5 Europe Microarray Market by Country
      • 6.2.1.6 Europe Others Market by Country
    • 6.2.2 Europe Pharmacogenomics Market by Application
      • 6.2.2.1 Europe Oncology Market by Country
      • 6.2.2.2 Europe Psychiatry Market by Country
      • 6.2.2.3 Europe Infectious Diseases Market by Country
      • 6.2.2.4 Europe Neurological Diseases Market by Country
      • 6.2.2.5 Europe Pain Management Market by Country
      • 6.2.2.6 Europe Cardiovascular Diseases Market by Country
      • 6.2.2.7 Europe Others Market by Country
    • 6.2.3 Europe Pharmacogenomics Market by End User
      • 6.2.3.1 Europe Hospitals and Clinics Market by Country
      • 6.2.3.2 Europe Research Institutions Market by Country
      • 6.2.3.3 Europe Academic Institutes Market by Country
    • 6.2.4 Europe Pharmacogenomics Market by Country
      • 6.2.4.1 Germany Pharmacogenomics Market
        • 6.2.4.1.1 Germany Pharmacogenomics Market by Technology
        • 6.2.4.1.2 Germany Pharmacogenomics Market by Application
        • 6.2.4.1.3 Germany Pharmacogenomics Market by End User
      • 6.2.4.2 UK Pharmacogenomics Market
        • 6.2.4.2.1 UK Pharmacogenomics Market by Technology
        • 6.2.4.2.2 UK Pharmacogenomics Market by Application
        • 6.2.4.2.3 UK Pharmacogenomics Market by End User
      • 6.2.4.3 France Pharmacogenomics Market
        • 6.2.4.3.1 France Pharmacogenomics Market by Technology
        • 6.2.4.3.2 France Pharmacogenomics Market by Application
        • 6.2.4.3.3 France Pharmacogenomics Market by End User
      • 6.2.4.4 Russia Pharmacogenomics Market
        • 6.2.4.4.1 Russia Pharmacogenomics Market by Technology
        • 6.2.4.4.2 Russia Pharmacogenomics Market by Application
        • 6.2.4.4.3 Russia Pharmacogenomics Market by End User
      • 6.2.4.5 Spain Pharmacogenomics Market
        • 6.2.4.5.1 Spain Pharmacogenomics Market by Technology
        • 6.2.4.5.2 Spain Pharmacogenomics Market by Application
        • 6.2.4.5.3 Spain Pharmacogenomics Market by End User
      • 6.2.4.6 Italy Pharmacogenomics Market
        • 6.2.4.6.1 Italy Pharmacogenomics Market by Technology
        • 6.2.4.6.2 Italy Pharmacogenomics Market by Application
        • 6.2.4.6.3 Italy Pharmacogenomics Market by End User
      • 6.2.4.7 Rest of Europe Pharmacogenomics Market
        • 6.2.4.7.1 Rest of Europe Pharmacogenomics Market by Technology
        • 6.2.4.7.2 Rest of Europe Pharmacogenomics Market by Application
        • 6.2.4.7.3 Rest of Europe Pharmacogenomics Market by End User
  • 6.3 Asia Pacific Pharmacogenomics Market
    • 6.3.1 Asia Pacific Pharmacogenomics Market by Technology
      • 6.3.1.1 Asia Pacific Sequencing Market by Country
      • 6.3.1.2 Asia Pacific Polymerase Chain Reaction Market by Country
      • 6.3.1.3 Asia Pacific Electrophoresis Market by Country
      • 6.3.1.4 Asia Pacific Mass Spectrometry Market by Country
      • 6.3.1.5 Asia Pacific Microarray Market by Country
      • 6.3.1.6 Asia Pacific Others Market by Country
    • 6.3.2 Asia Pacific Pharmacogenomics Market by Application
      • 6.3.2.1 Asia Pacific Oncology Market by Country
      • 6.3.2.2 Asia Pacific Psychiatry Market by Country
      • 6.3.2.3 Asia Pacific Infectious Diseases Market by Country
      • 6.3.2.4 Asia Pacific Neurological Diseases Market by Country
      • 6.3.2.5 Asia Pacific Pain Management Market by Country
      • 6.3.2.6 Asia Pacific Cardiovascular Diseases Market by Country
      • 6.3.2.7 Asia Pacific Others Market by Country
    • 6.3.3 Asia Pacific Pharmacogenomics Market by End User
      • 6.3.3.1 Asia Pacific Hospitals and Clinics Market by Country
      • 6.3.3.2 Asia Pacific Research Institutions Market by Country
      • 6.3.3.3 Asia Pacific Academic Institutes Market by Country
    • 6.3.4 Asia Pacific Pharmacogenomics Market by Country
      • 6.3.4.1 China Pharmacogenomics Market
        • 6.3.4.1.1 China Pharmacogenomics Market by Technology
        • 6.3.4.1.2 China Pharmacogenomics Market by Application
        • 6.3.4.1.3 China Pharmacogenomics Market by End User
      • 6.3.4.2 Japan Pharmacogenomics Market
        • 6.3.4.2.1 Japan Pharmacogenomics Market by Technology
        • 6.3.4.2.2 Japan Pharmacogenomics Market by Application
        • 6.3.4.2.3 Japan Pharmacogenomics Market by End User
      • 6.3.4.3 India Pharmacogenomics Market
        • 6.3.4.3.1 India Pharmacogenomics Market by Technology
        • 6.3.4.3.2 India Pharmacogenomics Market by Application
        • 6.3.4.3.3 India Pharmacogenomics Market by End User
      • 6.3.4.4 South Korea Pharmacogenomics Market
        • 6.3.4.4.1 South Korea Pharmacogenomics Market by Technology
        • 6.3.4.4.2 South Korea Pharmacogenomics Market by Application
        • 6.3.4.4.3 South Korea Pharmacogenomics Market by End User
      • 6.3.4.5 Singapore Pharmacogenomics Market
        • 6.3.4.5.1 Singapore Pharmacogenomics Market by Technology
        • 6.3.4.5.2 Singapore Pharmacogenomics Market by Application
        • 6.3.4.5.3 Singapore Pharmacogenomics Market by End User
      • 6.3.4.6 Malaysia Pharmacogenomics Market
        • 6.3.4.6.1 Malaysia Pharmacogenomics Market by Technology
        • 6.3.4.6.2 Malaysia Pharmacogenomics Market by Application
        • 6.3.4.6.3 Malaysia Pharmacogenomics Market by End User
      • 6.3.4.7 Rest of Asia Pacific Pharmacogenomics Market
        • 6.3.4.7.1 Rest of Asia Pacific Pharmacogenomics Market by Technology
        • 6.3.4.7.2 Rest of Asia Pacific Pharmacogenomics Market by Application
        • 6.3.4.7.3 Rest of Asia Pacific Pharmacogenomics Market by End User
  • 6.4 LAMEA Pharmacogenomics Market
    • 6.4.1 LAMEA Pharmacogenomics Market by Technology
      • 6.4.1.1 LAMEA Sequencing Market by Country
      • 6.4.1.2 LAMEA Polymerase Chain Reaction Market by Country
      • 6.4.1.3 LAMEA Electrophoresis Market by Country
      • 6.4.1.4 LAMEA Mass Spectrometry Market by Country
      • 6.4.1.5 LAMEA Microarray Market by Country
      • 6.4.1.6 LAMEA Others Market by Country
    • 6.4.2 LAMEA Pharmacogenomics Market by Application
      • 6.4.2.1 LAMEA Oncology Market by Country
      • 6.4.2.2 LAMEA Psychiatry Market by Country
      • 6.4.2.3 LAMEA Infectious Diseases Market by Country
      • 6.4.2.4 LAMEA Neurological Diseases Market by Country
      • 6.4.2.5 LAMEA Pain Management Market by Country
      • 6.4.2.6 LAMEA Cardiovascular Diseases Market by Country
      • 6.4.2.7 LAMEA Others Market by Country
    • 6.4.3 LAMEA Pharmacogenomics Market by End User
      • 6.4.3.1 LAMEA Hospitals and Clinics Market by Country
      • 6.4.3.2 LAMEA Research Institutions Market by Country
      • 6.4.3.3 LAMEA Academic Institutes Market by Country
    • 6.4.4 LAMEA Pharmacogenomics Market by Country
      • 6.4.4.1 Brazil Pharmacogenomics Market
        • 6.4.4.1.1 Brazil Pharmacogenomics Market by Technology
        • 6.4.4.1.2 Brazil Pharmacogenomics Market by Application
        • 6.4.4.1.3 Brazil Pharmacogenomics Market by End User
      • 6.4.4.2 Argentina Pharmacogenomics Market
        • 6.4.4.2.1 Argentina Pharmacogenomics Market by Technology
        • 6.4.4.2.2 Argentina Pharmacogenomics Market by Application
        • 6.4.4.2.3 Argentina Pharmacogenomics Market by End User
      • 6.4.4.3 UAE Pharmacogenomics Market
        • 6.4.4.3.1 UAE Pharmacogenomics Market by Technology
        • 6.4.4.3.2 UAE Pharmacogenomics Market by Application
        • 6.4.4.3.3 UAE Pharmacogenomics Market by End User
      • 6.4.4.4 Saudi Arabia Pharmacogenomics Market
        • 6.4.4.4.1 Saudi Arabia Pharmacogenomics Market by Technology
        • 6.4.4.4.2 Saudi Arabia Pharmacogenomics Market by Application
        • 6.4.4.4.3 Saudi Arabia Pharmacogenomics Market by End User
      • 6.4.4.5 South Africa Pharmacogenomics Market
        • 6.4.4.5.1 South Africa Pharmacogenomics Market by Technology
        • 6.4.4.5.2 South Africa Pharmacogenomics Market by Application
        • 6.4.4.5.3 South Africa Pharmacogenomics Market by End User
      • 6.4.4.6 Nigeria Pharmacogenomics Market
        • 6.4.4.6.1 Nigeria Pharmacogenomics Market by Technology
        • 6.4.4.6.2 Nigeria Pharmacogenomics Market by Application
        • 6.4.4.6.3 Nigeria Pharmacogenomics Market by End User
      • 6.4.4.7 Rest of LAMEA Pharmacogenomics Market
        • 6.4.4.7.1 Rest of LAMEA Pharmacogenomics Market by Technology
        • 6.4.4.7.2 Rest of LAMEA Pharmacogenomics Market by Application
        • 6.4.4.7.3 Rest of LAMEA Pharmacogenomics Market by End User

Chapter 7. Company Profiles

  • 7.1 ABBOTT Laboratories
    • 7.1.1 Company Overview
    • 7.1.2 Financial Analysis
    • 7.1.3 Segmental and Regional Analysis
    • 7.1.4 Research & Development Expense
    • 7.1.5 Recent strategies and developments:
      • 7.1.5.1 Collaborations, partnerships and agreements:
      • 7.1.5.2 Product launches:
      • 7.1.5.3 Acquisition and mergers:
    • 7.1.6 SWOT Analysis
  • 7.2 Empire Genomics LLC
    • 7.2.1 Company Overview
  • 7.3 Illumina, Inc.
    • 7.3.1 Company Overview
    • 7.3.2 Financial Analysis
    • 7.3.3 Regional& Segmental Analysis
    • 7.3.4 Research& Development Expenses
    • 7.3.5 Recent strategies and developments:
      • 7.3.5.1 Collaborations, partnerships and agreements:
      • 7.3.5.2 Product launches:
      • 7.3.5.3 Acquisition and mergers:
  • 7.4 OneOme LLC
    • 7.4.1 Company Overview
  • 7.5 Myriad Genetics Inc.
    • 7.5.1 Company Overview
    • 7.5.2 Financial Analysis
    • 7.5.3 Segmental and Regional Analysis
    • 7.5.4 Research & Development Expense
    • 7.5.5 Recent strategies and developments:
      • 7.5.5.1 Collaborations, partnerships and agreements:
      • 7.5.5.2 Product launches:
  • 7.6 Thermo Fischer Scientific, Inc.
    • 7.6.1 Company Overview
    • 7.6.2 Financial Analysis
    • 7.6.3 Segmental and Regional Analysis
    • 7.6.4 Research & Development Expense
    • 7.6.5 Recent strategies and developments:
      • 7.6.5.1 Collaborations, partnerships and agreements:
      • 7.6.5.2 Acquisition and mergers:
    • 7.6.6 SWOT Analysis
  • 7.7 Teva Pharmaceuticals Industries Ltd.
    • 7.7.1 Company Overview
    • 7.7.2 Financial Analysis
    • 7.7.3 Segmental Analysis
    • 7.7.4 Research & Development Expense
    • 7.7.5 Recent strategies and developments:
      • 7.7.5.1 Product launches:
  • 7.8 Bayer AG
    • 7.8.1 Company Overview
    • 7.8.2 Financial Analysis
    • 7.8.3 Segmental and Regional Analysis
    • 7.8.4 Research & Development Expense
    • 7.8.5 Recent strategies and developments:
      • 7.8.5.1 Collaborations, partnerships and agreements:
    • 7.8.6 SWOT Analysis
  • 7.9 Opko Health, Inc. (GeneDx, Inc.)
    • 7.9.1 Company Overview
    • 7.9.2 Financial Analysis
    • 7.9.3 Research & Development Expense
    • 7.9.4 Recent strategies and developments:
      • 7.9.4.1 Collaborations, partnerships and agreements:
      • 7.9.4.2 Product launches:
  • 7.1 Becton, Dickinson and Company
    • 7.10.1 Company Overview
    • 7.10.2 Financial Analysis
    • 7.10.3 Segmental and Regional Analysis
    • 7.10.4 Research & Development Expense
    • 7.10.5 Recent strategies and developments:
      • 7.10.5.1 Collaborations, partnerships and agreements:
      • 7.10.5.2 Acquisition and mergers:
      • 7.10.5.3 Product launches:
    • 7.10.6 SWOT Analysis

LIST OF TABLES

  • TABLE 1: GLOBAL PHARMACOGENOMICS MARKET, 2015 - 2018, USD MILLION
  • TABLE 2: GLOBAL PHARMACOGENOMICS MARKET, 2019 - 2025, USD MILLION
  • TABLE 3: GLOBAL PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
  • TABLE 4: GLOBAL PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
  • TABLE 5: GLOBAL SEQUENCING MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 6: GLOBAL SEQUENCING MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 7: GLOBAL POLYMERASE CHAIN REACTION MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 8: GLOBAL POLYMERASE CHAIN REACTION MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 9: GLOBAL ELECTROPHORESIS MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 10: GLOBAL ELECTROPHORESIS MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 11: GLOBAL MASS SPECTROMETRY MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 12: GLOBAL MASS SPECTROMETRY MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 13: GLOBAL MICROARRAY MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 14: GLOBAL MICROARRAY MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 15: GLOBAL OTHERS MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 16: GLOBAL OTHERS MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 17: GLOBAL PHARMACOGENOMICS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 18: GLOBAL PHARMACOGENOMICS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 19: GLOBAL ONCOLOGY MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 20: GLOBAL ONCOLOGY MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 21: GLOBAL PSYCHIATRY MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 22: GLOBAL PSYCHIATRY MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 23: GLOBAL INFECTIOUS DISEASES MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 24: GLOBAL INFECTIOUS DISEASES MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 25: GLOBAL NEUROLOGICAL DISEASES MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 26: GLOBAL NEUROLOGICAL DISEASES MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 27: GLOBAL PAIN MANAGEMENT MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 28: GLOBAL PAIN MANAGEMENT MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 29: GLOBAL CARDIOVASCULAR DISEASES MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 30: GLOBAL CARDIOVASCULAR DISEASES MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 31: GLOBAL OTHERS MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 32: GLOBAL OTHERS MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 33: GLOBAL PHARMACOGENOMICS MARKET BY END USER, 2015 - 2018, USD MILLION
  • TABLE 34: GLOBAL PHARMACOGENOMICS MARKET BY END USER, 2019 - 2025, USD MILLION
  • TABLE 35: GLOBAL HOSPITALS AND CLINICS MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 36: GLOBAL HOSPITALS AND CLINICS MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 37: GLOBAL RESEARCH INSTITUTIONS MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 38: GLOBAL RESEARCH INSTITUTIONS MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 39: GLOBAL ACADEMIC INSTITUTES MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 40: GLOBAL ACADEMIC INSTITUTES MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 41: GLOBAL PHARMACOGENOMICS MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 42: GLOBAL PHARMACOGENOMICS MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 43: NORTH AMERICA PHARMACOGENOMICS MARKET, 2015 - 2018, USD MILLION
  • TABLE 44: NORTH AMERICA PHARMACOGENOMICS MARKET, 2019 - 2025, USD MILLION
  • TABLE 45: NORTH AMERICA PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
  • TABLE 46: NORTH AMERICA PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
  • TABLE 47: NORTH AMERICA SEQUENCING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 48: NORTH AMERICA SEQUENCING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 49: NORTH AMERICA POLYMERASE CHAIN REACTION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 50: NORTH AMERICA POLYMERASE CHAIN REACTION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 51: NORTH AMERICA ELECTROPHORESIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 52: NORTH AMERICA ELECTROPHORESIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 53: NORTH AMERICA MASS SPECTROMETRY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 54: NORTH AMERICA MASS SPECTROMETRY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 55: NORTH AMERICA MICROARRAY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 56: NORTH AMERICA MICROARRAY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 57: NORTH AMERICA OTHERS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 58: NORTH AMERICA OTHERS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 59: NORTH AMERICA PHARMACOGENOMICS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 60: NORTH AMERICA PHARMACOGENOMICS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 61: NORTH AMERICA ONCOLOGY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 62: NORTH AMERICA ONCOLOGY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 63: NORTH AMERICA PSYCHIATRY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 64: NORTH AMERICA PSYCHIATRY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 65: NORTH AMERICA INFECTIOUS DISEASES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 66: NORTH AMERICA INFECTIOUS DISEASES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 67: NORTH AMERICA NEUROLOGICAL DISEASES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 68: NORTH AMERICA NEUROLOGICAL DISEASES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 69: NORTH AMERICA PAIN MANAGEMENT MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 70: NORTH AMERICA PAIN MANAGEMENT MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 71: NORTH AMERICA CARDIOVASCULAR DISEASES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 72: NORTH AMERICA CARDIOVASCULAR DISEASES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 73: NORTH AMERICA OTHERS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 74: NORTH AMERICA OTHERS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 75: NORTH AMERICA PHARMACOGENOMICS MARKET BY END USER, 2015 - 2018, USD MILLION
  • TABLE 76: NORTH AMERICA PHARMACOGENOMICS MARKET BY END USER, 2019 - 2025, USD MILLION
  • TABLE 77: NORTH AMERICA HOSPITALS AND CLINICS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 78: NORTH AMERICA HOSPITALS AND CLINICS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 79: NORTH AMERICA RESEARCH INSTITUTIONS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 80: NORTH AMERICA RESEARCH INSTITUTIONS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 81: NORTH AMERICA ACADEMIC INSTITUTES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 82: NORTH AMERICA ACADEMIC INSTITUTES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 83: NORTH AMERICA PHARMACOGENOMICS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 84: NORTH AMERICA PHARMACOGENOMICS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 85: USA PHARMACOGENOMICS MARKET, 2015 - 2018, USD MILLION
  • TABLE 86: USA PHARMACOGENOMICS MARKET, 2019 - 2025, USD MILLION
  • TABLE 87: USA PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
  • TABLE 88: USA PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
  • TABLE 89: USA PHARMACOGENOMICS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 90: USA PHARMACOGENOMICS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 91: USA PHARMACOGENOMICS MARKET BY END USER, 2015 - 2018, USD MILLION
  • TABLE 92: USA PHARMACOGENOMICS MARKET BY END USER, 2019 - 2025, USD MILLION
  • TABLE 93: CANADA PHARMACOGENOMICS MARKET, 2015 - 2018, USD MILLION
  • TABLE 94: CANADA PHARMACOGENOMICS MARKET, 2019 - 2025, USD MILLION
  • TABLE 95: CANADA PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
  • TABLE 96: CANADA PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
  • TABLE 97: CANADA PHARMACOGENOMICS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 98: CANADA PHARMACOGENOMICS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 99: CANADA PHARMACOGENOMICS MARKET BY END USER, 2015 - 2018, USD MILLION
  • TABLE 100: CANADA PHARMACOGENOMICS MARKET BY END USER, 2019 - 2025, USD MILLION
  • TABLE 101: MEXICO PHARMACOGENOMICS MARKET, 2015 - 2018, USD MILLION
  • TABLE 102: MEXICO PHARMACOGENOMICS MARKET, 2019 - 2025, USD MILLION
  • TABLE 103: MEXICO PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
  • TABLE 104: MEXICO PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
  • TABLE 105: MEXICO PHARMACOGENOMICS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 106: MEXICO PHARMACOGENOMICS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 107: MEXICO PHARMACOGENOMICS MARKET BY END USER, 2015 - 2018, USD MILLION
  • TABLE 108: MEXICO PHARMACOGENOMICS MARKET BY END USER, 2019 - 2025, USD MILLION
  • TABLE 109: REST OF NORTH AMERICA PHARMACOGENOMICS MARKET, 2015 - 2018, USD MILLION
  • TABLE 110: REST OF NORTH AMERICA PHARMACOGENOMICS MARKET, 2019 - 2025, USD MILLION
  • TABLE 111: REST OF NORTH AMERICA PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
  • TABLE 112: REST OF NORTH AMERICA PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
  • TABLE 113: REST OF NORTH AMERICA PHARMACOGENOMICS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 114: REST OF NORTH AMERICA PHARMACOGENOMICS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 115: REST OF NORTH AMERICA PHARMACOGENOMICS MARKET BY END USER, 2015 - 2018, USD MILLION
  • TABLE 116: REST OF NORTH AMERICA PHARMACOGENOMICS MARKET BY END USER, 2019 - 2025, USD MILLION
  • TABLE 117: EUROPE PHARMACOGENOMICS MARKET, 2015 - 2018, USD MILLION
  • TABLE 118: EUROPE PHARMACOGENOMICS MARKET, 2019 - 2025, USD MILLION
  • TABLE 119: EUROPE PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
  • TABLE 120: EUROPE PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
  • TABLE 121: EUROPE SEQUENCING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 122: EUROPE SEQUENCING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 123: EUROPE POLYMERASE CHAIN REACTION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 124: EUROPE POLYMERASE CHAIN REACTION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 125: EUROPE ELECTROPHORESIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 126: EUROPE ELECTROPHORESIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 127: EUROPE MASS SPECTROMETRY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 128: EUROPE MASS SPECTROMETRY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 129: EUROPE MICROARRAY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 130: EUROPE MICROARRAY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 131: EUROPE OTHERS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 132: EUROPE OTHERS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 133: EUROPE PHARMACOGENOMICS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 134: EUROPE PHARMACOGENOMICS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 135: EUROPE ONCOLOGY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 136: EUROPE ONCOLOGY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 137: EUROPE PSYCHIATRY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 138: EUROPE PSYCHIATRY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 139: EUROPE INFECTIOUS DISEASES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 140: EUROPE INFECTIOUS DISEASES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 141: EUROPE NEUROLOGICAL DISEASES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 142: EUROPE NEUROLOGICAL DISEASES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 143: EUROPE PAIN MANAGEMENT MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 144: EUROPE PAIN MANAGEMENT MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 145: EUROPE CARDIOVASCULAR DISEASES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 146: EUROPE CARDIOVASCULAR DISEASES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 147: EUROPE OTHERS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 148: EUROPE OTHERS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 149: EUROPE PHARMACOGENOMICS MARKET BY END USER, 2015 - 2018, USD MILLION
  • TABLE 150: EUROPE PHARMACOGENOMICS MARKET BY END USER, 2019 - 2025, USD MILLION
  • TABLE 151: EUROPE HOSPITALS AND CLINICS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 152: EUROPE HOSPITALS AND CLINICS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 153: EUROPE RESEARCH INSTITUTIONS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 154: EUROPE RESEARCH INSTITUTIONS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 155: EUROPE ACADEMIC INSTITUTES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 156: EUROPE ACADEMIC INSTITUTES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 157: EUROPE PHARMACOGENOMICS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 158: EUROPE PHARMACOGENOMICS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 159: GERMANY PHARMACOGENOMICS MARKET, 2015 - 2018, USD MILLION
  • TABLE 160: GERMANY PHARMACOGENOMICS MARKET, 2019 - 2025, USD MILLION
  • TABLE 161: GERMANY PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
  • TABLE 162: GERMANY PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
  • TABLE 163: GERMANY PHARMACOGENOMICS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 164: GERMANY PHARMACOGENOMICS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 165: GERMANY PHARMACOGENOMICS MARKET BY END USER, 2015 - 2018, USD MILLION
  • TABLE 166: GERMANY PHARMACOGENOMICS MARKET BY END USER, 2019 - 2025, USD MILLION
  • TABLE 167: UK PHARMACOGENOMICS MARKET, 2015 - 2018, USD MILLION
  • TABLE 168: UK PHARMACOGENOMICS MARKET, 2019 - 2025, USD MILLION
  • TABLE 169: UK PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
  • TABLE 170: UK PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
  • TABLE 171: UK PHARMACOGENOMICS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 172: UK PHARMACOGENOMICS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 173: UK PHARMACOGENOMICS MARKET BY END USER, 2015 - 2018, USD MILLION
  • TABLE 174: UK PHARMACOGENOMICS MARKET BY END USER, 2019 - 2025, USD MILLION
  • TABLE 175: FRANCE PHARMACOGENOMICS MARKET, 2015 - 2018, USD MILLION
  • TABLE 176: FRANCE PHARMACOGENOMICS MARKET, 2019 - 2025, USD MILLION
  • TABLE 177: FRANCE PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
  • TABLE 178: FRANCE PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
  • TABLE 179: FRANCE PHARMACOGENOMICS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 180: FRANCE PHARMACOGENOMICS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 181: FRANCE PHARMACOGENOMICS MARKET BY END USER, 2015 - 2018, USD MILLION
  • TABLE 182: FRANCE PHARMACOGENOMICS MARKET BY END USER, 2019 - 2025, USD MILLION
  • TABLE 183: RUSSIA PHARMACOGENOMICS MARKET, 2015 - 2018, USD MILLION
  • TABLE 184: RUSSIA PHARMACOGENOMICS MARKET, 2019 - 2025, USD MILLION
  • TABLE 185: RUSSIA PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
  • TABLE 186: RUSSIA PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
  • TABLE 187: RUSSIA PHARMACOGENOMICS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 188: RUSSIA PHARMACOGENOMICS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 189: RUSSIA PHARMACOGENOMICS MARKET BY END USER, 2015 - 2018, USD MILLION
  • TABLE 190: RUSSIA PHARMACOGENOMICS MARKET BY END USER, 2019 - 2025, USD MILLION
  • TABLE 191: SPAIN PHARMACOGENOMICS MARKET, 2015 - 2018, USD MILLION
  • TABLE 192: SPAIN PHARMACOGENOMICS MARKET, 2019 - 2025, USD MILLION
  • TABLE 193: SPAIN PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
  • TABLE 194: SPAIN PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
  • TABLE 195: SPAIN PHARMACOGENOMICS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 196: SPAIN PHARMACOGENOMICS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 197: SPAIN PHARMACOGENOMICS MARKET BY END USER, 2015 - 2018, USD MILLION
  • TABLE 198: SPAIN PHARMACOGENOMICS MARKET BY END USER, 2019 - 2025, USD MILLION
  • TABLE 199: ITALY PHARMACOGENOMICS MARKET, 2015 - 2018, USD MILLION
  • TABLE 200: ITALY PHARMACOGENOMICS MARKET, 2019 - 2025, USD MILLION
  • TABLE 201: ITALY PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
  • TABLE 202: ITALY PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
  • TABLE 203: ITALY PHARMACOGENOMICS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 204: ITALY PHARMACOGENOMICS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 205: ITALY PHARMACOGENOMICS MARKET BY END USER, 2015 - 2018, USD MILLION
  • TABLE 206: ITALY PHARMACOGENOMICS MARKET BY END USER, 2019 - 2025, USD MILLION
  • TABLE 207: REST OF EUROPE PHARMACOGENOMICS MARKET, 2015 - 2018, USD MILLION
  • TABLE 208: REST OF EUROPE PHARMACOGENOMICS MARKET, 2019 - 2025, USD MILLION
  • TABLE 209: REST OF EUROPE PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
  • TABLE 210: REST OF EUROPE PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
  • TABLE 211: REST OF EUROPE PHARMACOGENOMICS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 212: REST OF EUROPE PHARMACOGENOMICS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 213: REST OF EUROPE PHARMACOGENOMICS MARKET BY END USER, 2015 - 2018, USD MILLION
  • TABLE 214: REST OF EUROPE PHARMACOGENOMICS MARKET BY END USER, 2019 - 2025, USD MILLION
  • TABLE 215: ASIA PACIFIC PHARMACOGENOMICS MARKET, 2015 - 2018, USD MILLION
  • TABLE 216: ASIA PACIFIC PHARMACOGENOMICS MARKET, 2019 - 2025, USD MILLION
  • TABLE 217: ASIA PACIFIC PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
  • TABLE 218: ASIA PACIFIC PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
  • TABLE 219: ASIA PACIFIC SEQUENCING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 220: ASIA PACIFIC SEQUENCING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 221: ASIA PACIFIC POLYMERASE CHAIN REACTION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 222: ASIA PACIFIC POLYMERASE CHAIN REACTION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 223: ASIA PACIFIC ELECTROPHORESIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 224: ASIA PACIFIC ELECTROPHORESIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 225: ASIA PACIFIC MASS SPECTROMETRY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 226: ASIA PACIFIC MASS SPECTROMETRY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 227: ASIA PACIFIC MICROARRAY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 228: ASIA PACIFIC MICROARRAY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 229: ASIA PACIFIC OTHERS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 230: ASIA PACIFIC OTHERS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 231: ASIA PACIFIC PHARMACOGENOMICS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 232: ASIA PACIFIC PHARMACOGENOMICS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 233: ASIA PACIFIC ONCOLOGY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 234: ASIA PACIFIC ONCOLOGY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 235: ASIA PACIFIC PSYCHIATRY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 236: ASIA PACIFIC PSYCHIATRY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 237: ASIA PACIFIC INFECTIOUS DISEASES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 238: ASIA PACIFIC INFECTIOUS DISEASES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 239: ASIA PACIFIC NEUROLOGICAL DISEASES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 240: ASIA PACIFIC NEUROLOGICAL DISEASES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 241: ASIA PACIFIC PAIN MANAGEMENT MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 242: ASIA PACIFIC PAIN MANAGEMENT MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 243: ASIA PACIFIC CARDIOVASCULAR DISEASES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 244: ASIA PACIFIC CARDIOVASCULAR DISEASES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 245: ASIA PACIFIC OTHERS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 246: ASIA PACIFIC OTHERS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 247: ASIA PACIFIC PHARMACOGENOMICS MARKET BY END USER, 2015 - 2018, USD MILLION
  • TABLE 248: ASIA PACIFIC PHARMACOGENOMICS MARKET BY END USER, 2019 - 2025, USD MILLION
  • TABLE 249: ASIA PACIFIC HOSPITALS AND CLINICS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 250: ASIA PACIFIC HOSPITALS AND CLINICS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 251: ASIA PACIFIC RESEARCH INSTITUTIONS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 252: ASIA PACIFIC RESEARCH INSTITUTIONS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 253: ASIA PACIFIC ACADEMIC INSTITUTES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 254: ASIA PACIFIC ACADEMIC INSTITUTES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 255: ASIA PACIFIC PHARMACOGENOMICS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 256: ASIA PACIFIC PHARMACOGENOMICS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 257: CHINA PHARMACOGENOMICS MARKET, 2015 - 2018, USD MILLION
  • TABLE 258: CHINA PHARMACOGENOMICS MARKET, 2019 - 2025, USD MILLION
  • TABLE 259: CHINA PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
  • TABLE 260: CHINA PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
  • TABLE 261: CHINA PHARMACOGENOMICS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 262: CHINA PHARMACOGENOMICS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 263: CHINA PHARMACOGENOMICS MARKET BY END USER, 2015 - 2018, USD MILLION
  • TABLE 264: CHINA PHARMACOGENOMICS MARKET BY END USER, 2019 - 2025, USD MILLION
  • TABLE 265: JAPAN PHARMACOGENOMICS MARKET, 2015 - 2018, USD MILLION
  • TABLE 266: JAPAN PHARMACOGENOMICS MARKET, 2019 - 2025, USD MILLION
  • TABLE 267: JAPAN PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
  • TABLE 268: JAPAN PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
  • TABLE 269: JAPAN PHARMACOGENOMICS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 270: JAPAN PHARMACOGENOMICS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 271: JAPAN PHARMACOGENOMICS MARKET BY END USER, 2015 - 2018, USD MILLION
  • TABLE 272: JAPAN PHARMACOGENOMICS MARKET BY END USER, 2019 - 2025, USD MILLION
  • TABLE 273: INDIA PHARMACOGENOMICS MARKET, 2015 - 2018, USD MILLION
  • TABLE 274: INDIA PHARMACOGENOMICS MARKET, 2019 - 2025, USD MILLION
  • TABLE 275: INDIA PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
  • TABLE 276: INDIA PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
  • TABLE 277: INDIA PHARMACOGENOMICS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 278: INDIA PHARMACOGENOMICS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 279: INDIA PHARMACOGENOMICS MARKET BY END USER, 2015 - 2018, USD MILLION
  • TABLE 280: INDIA PHARMACOGENOMICS MARKET BY END USER, 2019 - 2025, USD MILLION
  • TABLE 281: SOUTH KOREA PHARMACOGENOMICS MARKET, 2015 - 2018, USD MILLION
  • TABLE 282: SOUTH KOREA PHARMACOGENOMICS MARKET, 2019 - 2025, USD MILLION
  • TABLE 283: SOUTH KOREA PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
  • TABLE 284: SOUTH KOREA PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
  • TABLE 285: SOUTH KOREA PHARMACOGENOMICS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 286: SOUTH KOREA PHARMACOGENOMICS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 287: SOUTH KOREA PHARMACOGENOMICS MARKET BY END USER, 2015 - 2018, USD MILLION
  • TABLE 288: SOUTH KOREA PHARMACOGENOMICS MARKET BY END USER, 2019 - 2025, USD MILLION
  • TABLE 289: SINGAPORE PHARMACOGENOMICS MARKET, 2015 - 2018, USD MILLION
  • TABLE 290: SINGAPORE PHARMACOGENOMICS MARKET, 2019 - 2025, USD MILLION
  • TABLE 291: SINGAPORE PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
  • TABLE 292: SINGAPORE PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
  • TABLE 293: SINGAPORE PHARMACOGENOMICS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 294: SINGAPORE PHARMACOGENOMICS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 295: SINGAPORE PHARMACOGENOMICS MARKET BY END USER, 2015 - 2018, USD MILLION
  • TABLE 296: SINGAPORE PHARMACOGENOMICS MARKET BY END USER, 2019 - 2025, USD MILLION
  • TABLE 297: MALAYSIA PHARMACOGENOMICS MARKET, 2015 - 2018, USD MILLION
  • TABLE 298: MALAYSIA PHARMACOGENOMICS MARKET, 2019 - 2025, USD MILLION
  • TABLE 299: MALAYSIA PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
  • TABLE 300: MALAYSIA PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
  • TABLE 301: MALAYSIA PHARMACOGENOMICS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 302: MALAYSIA PHARMACOGENOMICS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 303: MALAYSIA PHARMACOGENOMICS MARKET BY END USER, 2015 - 2018, USD MILLION
  • TABLE 304: MALAYSIA PHARMACOGENOMICS MARKET BY END USER, 2019 - 2025, USD MILLION
  • TABLE 305: REST OF ASIA PACIFIC PHARMACOGENOMICS MARKET, 2015 - 2018, USD MILLION
  • TABLE 306: REST OF ASIA PACIFIC PHARMACOGENOMICS MARKET, 2019 - 2025, USD MILLION
  • TABLE 307: REST OF ASIA PACIFIC PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
  • TABLE 308: REST OF ASIA PACIFIC PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
  • TABLE 309: REST OF ASIA PACIFIC PHARMACOGENOMICS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 310: REST OF ASIA PACIFIC PHARMACOGENOMICS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 311: REST OF ASIA PACIFIC PHARMACOGENOMICS MARKET BY END USER, 2015 - 2018, USD MILLION
  • TABLE 312: REST OF ASIA PACIFIC PHARMACOGENOMICS MARKET BY END USER, 2019 - 2025, USD MILLION
  • TABLE 313: LAMEA PHARMACOGENOMICS MARKET, 2015 - 2018, USD MILLION
  • TABLE 314: LAMEA PHARMACOGENOMICS MARKET, 2019 - 2025, USD MILLION
  • TABLE 315: LAMEA PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
  • TABLE 316: LAMEA PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
  • TABLE 317: LAMEA SEQUENCING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 318: LAMEA SEQUENCING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 319: LAMEA POLYMERASE CHAIN REACTION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 320: LAMEA POLYMERASE CHAIN REACTION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 321: LAMEA ELECTROPHORESIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 322: LAMEA ELECTROPHORESIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 323: LAMEA MASS SPECTROMETRY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 324: LAMEA MASS SPECTROMETRY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 325: LAMEA MICROARRAY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 326: LAMEA MICROARRAY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 327: LAMEA OTHERS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 328: LAMEA OTHERS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 329: LAMEA PHARMACOGENOMICS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 330: LAMEA PHARMACOGENOMICS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 331: LAMEA ONCOLOGY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 332: LAMEA ONCOLOGY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 333: LAMEA PSYCHIATRY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 334: LAMEA PSYCHIATRY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 335: LAMEA INFECTIOUS DISEASES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 336: LAMEA INFECTIOUS DISEASES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 337: LAMEA NEUROLOGICAL DISEASES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 338: LAMEA NEUROLOGICAL DISEASES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 339: LAMEA PAIN MANAGEMENT MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 340: LAMEA PAIN MANAGEMENT MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 341: LAMEA CARDIOVASCULAR DISEASES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 342: LAMEA CARDIOVASCULAR DISEASES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 343: LAMEA OTHERS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 344: LAMEA OTHERS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 345: LAMEA PHARMACOGENOMICS MARKET BY END USER, 2015 - 2018, USD MILLION
  • TABLE 346: LAMEA PHARMACOGENOMICS MARKET BY END USER, 2019 - 2025, USD MILLION
  • TABLE 347: LAMEA HOSPITALS AND CLINICS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 348: LAMEA HOSPITALS AND CLINICS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 349: LAMEA RESEARCH INSTITUTIONS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 350: LAMEA RESEARCH INSTITUTIONS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 351: LAMEA ACADEMIC INSTITUTES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 352: LAMEA ACADEMIC INSTITUTES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 353: LAMEA PHARMACOGENOMICS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 354: LAMEA PHARMACOGENOMICS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 355: BRAZIL PHARMACOGENOMICS MARKET, 2015 - 2018, USD MILLION
  • TABLE 356: BRAZIL PHARMACOGENOMICS MARKET, 2019 - 2025, USD MILLION
  • TABLE 357: BRAZIL PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
  • TABLE 358: BRAZIL PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
  • TABLE 359: BRAZIL PHARMACOGENOMICS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 360: BRAZIL PHARMACOGENOMICS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 361: BRAZIL PHARMACOGENOMICS MARKET BY END USER, 2015 - 2018, USD MILLION
  • TABLE 362: BRAZIL PHARMACOGENOMICS MARKET BY END USER, 2019 - 2025, USD MILLION
  • TABLE 363: ARGENTINA PHARMACOGENOMICS MARKET, 2015 - 2018, USD MILLION
  • TABLE 364: ARGENTINA PHARMACOGENOMICS MARKET, 2019 - 2025, USD MILLION
  • TABLE 365: ARGENTINA PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
  • TABLE 366: ARGENTINA PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
  • TABLE 367: ARGENTINA PHARMACOGENOMICS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 368: ARGENTINA PHARMACOGENOMICS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 369: ARGENTINA PHARMACOGENOMICS MARKET BY END USER, 2015 - 2018, USD MILLION
  • TABLE 370: ARGENTINA PHARMACOGENOMICS MARKET BY END USER, 2019 - 2025, USD MILLION
  • TABLE 371: UAE PHARMACOGENOMICS MARKET, 2015 - 2018, USD MILLION
  • TABLE 372: UAE PHARMACOGENOMICS MARKET, 2019 - 2025, USD MILLION
  • TABLE 373: UAE PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
  • TABLE 374: UAE PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
  • TABLE 375: UAE PHARMACOGENOMICS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 376: UAE PHARMACOGENOMICS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 377: UAE PHARMACOGENOMICS MARKET BY END USER, 2015 - 2018, USD MILLION
  • TABLE 378: UAE PHARMACOGENOMICS MARKET BY END USER, 2019 - 2025, USD MILLION
  • TABLE 379: SAUDI ARABIA PHARMACOGENOMICS MARKET, 2015 - 2018, USD MILLION
  • TABLE 380: SAUDI ARABIA PHARMACOGENOMICS MARKET, 2019 - 2025, USD MILLION
  • TABLE 381: SAUDI ARABIA PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
  • TABLE 382: SAUDI ARABIA PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
  • TABLE 383: SAUDI ARABIA PHARMACOGENOMICS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 384: SAUDI ARABIA PHARMACOGENOMICS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 385: SAUDI ARABIA PHARMACOGENOMICS MARKET BY END USER, 2015 - 2018, USD MILLION
  • TABLE 386: SAUDI ARABIA PHARMACOGENOMICS MARKET BY END USER, 2019 - 2025, USD MILLION
  • TABLE 387: SOUTH AFRICA PHARMACOGENOMICS MARKET, 2015 - 2018, USD MILLION
  • TABLE 388: SOUTH AFRICA PHARMACOGENOMICS MARKET, 2019 - 2025, USD MILLION
  • TABLE 389: SOUTH AFRICA PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
  • TABLE 390: SOUTH AFRICA PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
  • TABLE 391: SOUTH AFRICA PHARMACOGENOMICS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 392: SOUTH AFRICA PHARMACOGENOMICS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 393: SOUTH AFRICA PHARMACOGENOMICS MARKET BY END USER, 2015 - 2018, USD MILLION
  • TABLE 394: SOUTH AFRICA PHARMACOGENOMICS MARKET BY END USER, 2019 - 2025, USD MILLION
  • TABLE 395: NIGERIA PHARMACOGENOMICS MARKET, 2015 - 2018, USD MILLION
  • TABLE 396: NIGERIA PHARMACOGENOMICS MARKET, 2019 - 2025, USD MILLION
  • TABLE 397: NIGERIA PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
  • TABLE 398: NIGERIA PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
  • TABLE 399: NIGERIA PHARMACOGENOMICS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 400: NIGERIA PHARMACOGENOMICS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 401: NIGERIA PHARMACOGENOMICS MARKET BY END USER, 2015 - 2018, USD MILLION
  • TABLE 402: NIGERIA PHARMACOGENOMICS MARKET BY END USER, 2019 - 2025, USD MILLION
  • TABLE 403: REST OF LAMEA PHARMACOGENOMICS MARKET, 2015 - 2018, USD MILLION
  • TABLE 404: REST OF LAMEA PHARMACOGENOMICS MARKET, 2019 - 2025, USD MILLION
  • TABLE 405: REST OF LAMEA PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
  • TABLE 406: REST OF LAMEA PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
  • TABLE 407: REST OF LAMEA PHARMACOGENOMICS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 408: REST OF LAMEA PHARMACOGENOMICS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 409: REST OF LAMEA PHARMACOGENOMICS MARKET BY END USER, 2015 - 2018, USD MILLION
  • TABLE 410: REST OF LAMEA PHARMACOGENOMICS MARKET BY END USER, 2019 - 2025, USD MILLION
  • TABLE 411: KEY INFORMATION - ABBOTT LABORATORIES
  • TABLE 412: KEY INFORMATION - EMPIRE GENOMICS LLC
  • TABLE 413: KEY INFORMATION - ILLUMINA, INC.
  • TABLE 414: KEY INFORMATION - ONEOME LLC
  • TABLE 415: KEY INFORMATION - MYRIAD GENETICS INC.
  • TABLE 416: KEY INFORMATION - THERMO FISHER SCIENTIFIC, INC.
  • TABLE 417: KEY INFORMATION - TEVA PHARMACEUTICALS INDUSTRIES LTD.
  • TABLE 418: KEY INFORMATION - BAYER AG
  • TABLE 419: KEY INFORMATION - OPKO HEALTH, INC.
  • TABLE 420: KEY INFORMATION - BECTON, DICKINSON AND COMPANY

LIST OF FIGURES

  • FIG 1: METHODOLOGY FOR THE RESEARCH
  • FIG 2: SWOT ANALYSIS: ABBOTT LABORATORIES
  • FIG 3: SWOT ANALYSIS: THERMO FISHER SCIENTIFIC, INC.
  • FIG 4: SWOT ANALYSIS: BAYER AG
  • FIG 5: SWOT ANALYSIS: BECTON, DICKINSON AND COMPANY
Back to Top